Shireen Sirhan

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, Mythri Mudireddy, Maura Nicolosi et al. · Mayo Clinic Proceedings · 2019 · 151 citations

Hematological Malignancy, Medicine, Outcomes Data +10

A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

Vikas Gupta, Ruben A. Mesa, Michael W. Deininger et al. · Haematologica · 2016 · 94 citations · Full text

Concomitant neutrophil <i>JAK2</i>^V617F mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia

Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho et al. · British Journal of Haematology · 2005 · 90 citations · Full text

Immunohematology, Mixed-phenotype Acute Leukemia, Immunodeficiencies +22

Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients

Brijesh Arora, Shireen Sirhan, James D. Hoyer et al. · British Journal of Haematology · 2004 · 49 citations · Full text

Red cell mass and plasma volume measurements in polycythemia:

Shireen Sirhan, Virgil F. Fairbanks, Ayalew Tefferi · Cancer · 2005 · 46 citations · Full text